Nexalin Technology - Multiplikator nilai perusahaan marang pendapatan NXL

Nexalin Technology, Inc. (NXL) designs neurostimulators, outsourcing final assembly to external partners under strict medical supervision. The EV-to-revenue ratio on GURU.Markets reflects the valuation trend, where the metric remains around 7714.29. The company develops non-invasive, drug-free methods for combating anxiety while adhering to standard environmental safety regulations within its laboratories.
NXL (Nexalin): rincian analitis lan laporan miturut indikator

Recurring revenues for Nexalin Technology, Inc. (NXL) from the sale of brain stimulation consumables make the Enterprise Value-to-Revenue (EV/Revenue) multiple a key indicator of investment attractiveness. This metric compares market capitalization and net debt against sales volume, allowing for a business valuation independent of financing structure and confirming the stability of the issuer's position.